SARS COV-2 DELTA VARIANT STRUCTURAL PROTEINS: HOMOLOGY WITH OPPORTUNISTIC BACTERIA

  • A.T. Maryanovich North-Western Medical University named after I.I. Mechnikov. Kirochnaya 41, Saint Petersburg, Russian Federation, 191015 https://orcid.org/0000-0001-7482-3403
  • D.Yu. Kormilets Military Medical Academy named after S.M. Kirov. Akademician Lebedeva St., 6, Saint Petersburg, Russian Federation, 194044
Keywords: SARS CoV-2, Delta variant, spike protein, opportunistic bacteria, homology

Abstract

The capacity of SARS CoV-2 for immune evasion can be considered universally recognized. Coronavirus and human protein homology may be one of the mechanisms of immune evasion. Delta variant necessarily has structural features that explain its specific qualities. The aim of our study is to find out whether mutations in the structural proteins of Delta variant change its homology with proteins present in the human body, i.e. human, bacterial and dietary. Using bioinformatics tools we detected homology on the heptamer level between Delta variant structural proteins and human proteins as well as some opportunistic bacteria proteins of the upper respiratory tract, lung and gut. Delta variant spike (S) and membrane (M) proteins have a large number of similarities (homologous correspondences) with the listed proteins, with the S:Δ156,157;R158G mutation having the greatest amount. The reason why SARS CoV-2 Delta variant has specific characteristics, most importantly increased lethality, is most likely to be found in a mutation at positions 156–158 of spike protein.

References

Elrashdy F., Redwan E.M. & Uversky V.N. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics? Biomolecules. 2020;10:1312. DOI: 10.3390/biom10091312.

Seyran M. et al. The structural basis of accelerated host cell entry by SARS-CoV-2. FEBS J. 2021;288:5010–5020. DOI: 10.1111/febs.15651.

Fang F.F. & Shi P.Y. Omicron a drug developer’s pers­pective. Emerg Microbes Infect. 2022;11:208–211. DOI: 10.1080/22221751.2021.2023330.

Beaudoin C.A. et al. Predicted structural mimicry of spike receptor-bin­ding motifs from highly pathogenic human coronaviruses. Comput Struct Biotechnol. J. 2021;19:3938–3953. DOI: 10.1016/j.csbj.2021.06.041.

Khavinson V. et al. Homology between SARS CoV-2 and human proteins. Sci Rep. 2021;11:17199. DOI: 10.1038/s41598-021-96233-7.

Kwarteng A. et al. Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutra­lizing antibodies, A computational approach. Infect. Genet Evol. 2021;91:104815. DOI: 10.1016/j.meegid.2021.104815.

McSharry B.P., Avdic S. & Slobedman B. Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors, roles in immunomodulation. Viruses. 2012;4:2448–2470. DOI: 10.3390/v4112448.

Lederberg J. Infectious history. Science. 2000;288:287–293.

Planas D. et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021;596:276–280. DOI: 10.1038/s41586-021-03777-9.

Shen L. et al. Emerging variants of concern in SARS-CoV-2 membrane protein, a highly conserved target with potential pathological and therapeutic implications. Emerg Microbes Infect. 2021;10:885–893. DOI: 10.1080/22221751.2021.1922097.

Perez-Gomez R. The Development of SARS-CoV-2 Variants, The Gene Makes the Disease. J Dev Biol. 2021;9:58. DOI: 10.3390/jdb9040058.

Damoiseaux J. et al. Autoantibodies and SARS-CoV2 infection, The spectrum from association to clinical implication, Report of the 15th Dresden Symposium on Autoantibodies. Autoimmun Rev. 2021;21:103012. DOI: j.autrev.2021.103012.

Wang Y. et al. Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou. China Eclinical Medicine. 2021;40:101129. DOI: 10.1016/j.eclinm.2021.101129.

Dessì A., Bosco A., Pintus R., Orrù G. & Fanos V. Fusobacte­rium nucleatum and alteration of the oral microbiome, from pregnancy to SARS-COV-2 infection. Eur Rev Med Pharmacol Sci. 2021;25:4579–4596. DOI: 10.26355/eurrev_202107_26251.

Filomena M. C. et al. Myopalladin knockout mice develop cardiac dilation and show a maladaptive response to mechanical pressure overload. Elife. 2021;24:e58313. DOI: 10.7554/eLife.58313.

Massilamany C. et al. Whole genomic sequence analysis of, defining the genetic blueprint of strain NRRL B-14911, an emerging cardiopathogenic microbe. BMC Genomics. 2016;17(Suppl 7):511. DOI: 10.1186/s12864-016-2900-2.

Laino M. E. et al. Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement. Clin Rev Allergy Immunol. 2022;28:1–15. DOI: 10.1007/s12016-022-08925-1.

Proteomes — Homo sapiens (Human). URL: https //www.uniprot.org/proteomes/UP000005640 Homo sapiens, last change, 03 Sept 2020. (access: 24.04.2024)

Proteomes — Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2). URL: https//www.uniprot.org/proteomes/UP000464024 SARS-COV-2, last change, 20 Aug 2020. (access: 24.04.2024)

Published
2024-07-31
How to Cite
Maryanovich, A., & Kormilets, D. (2024). SARS COV-2 DELTA VARIANT STRUCTURAL PROTEINS: HOMOLOGY WITH OPPORTUNISTIC BACTERIA. Russian Biomedical Research, 9(2), 5-17. https://doi.org/10.56871/RBR.2024.63.31.001
Section
Статьи